Search
for
Sort by
Research 511–540 of 1000+
- Clinical experiences on alopecia areata treatment with tofacitinib: A study of 63 patients
- Pegylated-interferon-α<sub>2a</sub>in clinical practice: how to manage patients suffering from side effects
- Treatment of male and female pattern hair loss with sublingual minoxidil: a retrospective case‐series of 64 patients
- Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study
- Characteristics and Alternative Treatment Outcomes of Antimalarial-Refractory Cutaneous Lupus Erythematosus
- Trichologic response of platelet-rich plasma in androgenetic alopecia is maintained during combination therapy
- Chemical Peels: Indications and Special Considerations for the Male Patient
- 5-Alpha-Reductase Inhibitors and Combination Therapy
- Comparative Evaluation of the Clinical Efficacy of PRP-Therapy, Minoxidil, and Their Combination with Immunohistochemical Study of the Dynamics of Cell Proliferation in the Treatment of Men with Androgenetic Alopecia
- New treatments for rheumatoid arthritis
- Oral isotretinoin combined with topical clobetasol 0.05% and tacrolimus 0.1% for the treatment of frontal fibrosing alopecia: a randomized controlled trial
- Integral Roles of Specific Proteoglycans in Hair Growth and Hair Loss: Mechanisms behind the Bioactivity of Proteoglycan Replacement Therapy with Nourkrin® with Marilex® in Pattern Hair Loss and Telogen Effluvium
- Antiandrogenic drugs, a therapeutic option for frontal fibrosing alopecia patients
- Comparative evaluation between two nutritional supplements in the improvement of telogen effluvium
- A novel mutation in the FERMT1 gene in a Spanish family with Kindler’s syndrome
- Treatment Patterns and Treatment Satisfaction Among Adults with Alopecia Areata in the United States
- Follicular Transplantation, Microneedling, and Adjuvant Narrow-band Ultraviolet-B Irradiation as Cost-Effective Regimens for Palmar-Plantar Vitiligo: A Pilot Study
- Adverse cutaneous effects of psychotropic medications
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- Effectiveness of fractional erbium–YAG laser, microneedling, platelet-rich plasma in localized stable vitiligo patients: randomized clinical trial
- Endocrine disorders and hormonal therapy for adolescent acne
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Role of Sodium–Glucose Cotransporter-2 Inhibitors in Managing Polycystic Ovary Syndrome: A Systematic Review
- Alopecia areata universalis nach Sitagliptin-Einnahme
- Lichen planopilaris in men: a retrospective clinicopathologic study of 19 patients
- The clinical effect of JetpPeel-assisted topical minoxidil in the treatment of androgenetic alopecia: A randomized pilot study
- Association Between 5α-Reductase Inhibitors and Prostate Cancer Mortality
- TREATMENT OF SEVERE ALOPECIA AREATA USING METHOTREXATE AS AN ADJUNCTIVE DRUG IN COMBINATION WITH INTRAVENOUS AND ORAL CORTICOSTEROID
- TOPICAL EFLORNITHINE TREATMENT FOR HIRSUTISM IN WOMEN: SUMMARY OF FINDINGS
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team